乘聯會:12月比亞迪新能源批發銷量93338輛、特斯拉中國70847輛
格隆匯1月11日丨乘聯會數據顯示,12月新能源乘用車市場多元化發力,廠商批發銷量突破萬輛的企業有14家,較前期大幅增多,其中:比亞迪93338輛、特斯拉中國70847輛、上汽通用五菱60372輛、長城汽車20926輛、奇瑞汽車20501輛、吉利汽車16831輛、小鵬汽車16000輛、上汽乘用車14868輛、廣汽埃安14500輛、理想汽車14087輛、一汽大衆11213輛、蔚來汽車10489輛、長安汽車10404輛、合衆汽車10127輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.